These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir. Arasli M; Ustundag Y; Delikanli B; Harmandar F; Buyukuysal C Hepatogastroenterology; 2012 May; 59(115):851-7. PubMed ID: 22193343 [TBL] [Abstract][Full Text] [Related]
5. Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-alpha therapy in patients with chronic hepatitis B. Fei GZ; Sylvan SP; Yao GB; Hellström UB J Viral Hepat; 1999 May; 6(3):219-27. PubMed ID: 10607234 [TBL] [Abstract][Full Text] [Related]
6. CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection. Wongjitrat C; Sukwit S; Chuenchitra T; Seangjaruk P; Rojanasang P; Romputtan P; Srisurapanon S J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S54-9. PubMed ID: 23724456 [TBL] [Abstract][Full Text] [Related]
7. A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment. Diao H; He J; Zheng Q; Chen J; Cui G; Wei Y; Ye P; Kohanawa M; Li L Immunol Lett; 2014 Jul; 160(1):65-71. PubMed ID: 24718278 [TBL] [Abstract][Full Text] [Related]
8. Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients. Cao W; Qiu ZF; Li TS World J Gastroenterol; 2011 May; 17(17):2191-8. PubMed ID: 21633528 [TBL] [Abstract][Full Text] [Related]
9. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection. Li J; Han Y; Jin K; Wan Y; Wang S; Liu B; Liu Y; Lu S; Huang Z Virol J; 2011 May; 8():199. PubMed ID: 21535873 [TBL] [Abstract][Full Text] [Related]
10. [Changes in lymphocyte surface expression of CD8 and CD38 molecules in peripheral blood of inactive HBsAg carriers following pegylated interferon a-2a therapy]. Yu HB; Ma LN; Liu YL; Hua W; He ZM; Lu JF; Chen XY Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):895-8. PubMed ID: 24636289 [TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic profile of intrahepatic and circulating lymphocytes in chronic hepatitis B patients. Tan G; Zhao W; Liu X; Wang J; Wu Y Hepatogastroenterology; 2012; 59(117):1516-21. PubMed ID: 22155852 [TBL] [Abstract][Full Text] [Related]
12. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection. Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246 [TBL] [Abstract][Full Text] [Related]
13. Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion. Bruder Costa J; Dufeu-Duchesne T; Leroy V; Bertucci I; Bouvier-Alias M; Pouget N; Brevot-Lutton O; Bourliere M; Zoulim F; Plumas J; Aspord C; PLoS One; 2016; 11(6):e0158297. PubMed ID: 27348813 [TBL] [Abstract][Full Text] [Related]
14. Natural Killer Group 2A Expressed on Both Peripheral CD3 Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717 [TBL] [Abstract][Full Text] [Related]
15. Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection. Wu W; Shi Y; Li J; Chen F; Chen Z; Zheng M Virol J; 2011 Mar; 8():113. PubMed ID: 21392402 [TBL] [Abstract][Full Text] [Related]
16. Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection. Aspord C; Bruder Costa J; Jacob MC; Dufeu-Duchesne T; Bertucci I; Pouget N; Brevot-Lutton O; Zoulim F; Bourliere M; Plumas J; Leroy V; PLoS One; 2016; 11(6):e0156200. PubMed ID: 27281019 [TBL] [Abstract][Full Text] [Related]
17. Changes in the proportions of CD4(+)T cell subsets defined by CD127 and CD25 expression during HBV infection. Xu HT; Ye J; Chen YB; Zhang LX; Huang JX; Xian JC; Liu L; Peng HL; Li L; Lin M; Huang JH Immunol Invest; 2012; 41(3):290-303. PubMed ID: 22122423 [TBL] [Abstract][Full Text] [Related]
18. Circulating PD-1 Zhang L; Li H; Ren H; Hu P Mol Immunol; 2018 Nov; 103():270-278. PubMed ID: 30340072 [TBL] [Abstract][Full Text] [Related]
19. [Difference and significance of peripheral blood T-lymphocyte subsets in patients with chronic hepatitis B and asymptomatic HBV carriers]. Tian Y; Qiu ZF; Li TS Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3354-8. PubMed ID: 16409844 [TBL] [Abstract][Full Text] [Related]
20. Recovery of circulating CD56 Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]